Learn How Barley Beta-Glucan 'Water' Reduces Diabetes Risk and Insulin Sensitivity Kirk Hamilton interviews Dr. Joy L. Frestedt a PhD in Laboratory Medicine and Pathology from the University of Minnesota Medical School; a certified clinical trial investigator; a fellow of the Regulatory Affairs Professionals Society; and is currently the president and CEO of Frestedt Incorporated which provides services in regulatory, clinical, and quality affairs. Dr. Frestedt is the co-author of a paper entitled: "Reduced Viscosity Barley Beta-Glucan Versus Placebo: A Randomized Controlled Trial of The Effects on Insulin Sensitivity for Individuals at Risk for Diabetes Mellitus," in the journal Nutrition and Metabolism in August of 2011. Download or Open: